Who Is Really “Gambling With World War III”?
March 29, 2025
Ampersand wins £22m five-year contract at London Zoo
June 25, 2012
Britons support ninja swords ban
March 29, 2025
The FINANCIAL -- Women diagnosed and treated for breast cancer have increased biological aging compared to women who remain free ...
The FINANCIAL -- A cancer researcher and consultant has estimated for the first time how many women are living with secondary ...
The FINANCIAL -- Cambridge scientists have created a comprehensive tool for predicting an individual’s risk of developing prostate cancer, which ...
Former smokers who stick to a healthy lifestyle have a lower risk of dying from all causes than those who ...
The FINANCIAL -- Altered microbiome, sleep deprivation, increase in alcohol consumption among possible culprits in 30-year global trend According to Harvard ...
The FINANCIAL -- First major study to investigate dairy consumption and cancer risk in Chinese adults has found that greater ...
The FINANCIAL -- A Merseyside man has become the first in the UK to receive a ‘vaccine’ that is hoped ...
The FINANCIAL -- While mammograms reduce breast cancer mortality by 15-20%, the diagnosis in many cases—approximately 15% of all breast ...
The FINANCIAL -- Scientists from the University of Oxford and the Ludwig Institute for Cancer Research are building on the success ...
The FINANCIAL -- In children with rhabdomyosarcoma, or RMS, a rare cancer that affects the muscles and other soft tissues, ...
The FINANCIAL -- Researchers aim to develop tiny robotic sensors to detect bowel cancers, the second most common cause of ...
The FINANCIAL -- Postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that has ...
The FINANCIAL -- The global pandemic of the coronavirus disease, called COVID-19, continues to have a serious impact on many ...
The FINANCIAL -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that the China National ...
The FINANCIAL -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has approved Tecentriq® (atezolizumab) in ...